TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
1. TransCode announces a 1-for-33 reverse stock split effective December 4, 2024. 2. This split aims to boost the stock price for Nasdaq compliance. 3. Post-split, outstanding shares will decrease from 17.3 million to 696,233. 4. No fractional shares will be issued; shares will round to the nearest whole. 5. The company's CUSIP number will change as part of the split.